Chong Kun Dang Pharmaceutical Corp. - Company Profile

Powered by

All the data and insights you need on Chong Kun Dang Pharmaceutical Corp. in one report.

  • Save hours of research time and resources with
    our up-to-date Chong Kun Dang Pharmaceutical Corp. Strategy Report

  • Understand Chong Kun Dang Pharmaceutical Corp. position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

Back to companies

Chong Kun Dang Pharmaceutical Corp.: Executives

The following section provides information on Chong Kun Dang Pharmaceutical Corp.’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Chong Kun Dang Pharmaceutical Corp.'s management and employees, unlock the full data with our company analytics monitoring tool.

Executives

Young-Joo Kim

Chief Executive Officer; President Senior Management Since: 2021

Mr. Kim Young-joo has been the Chief Executive Officer and Chairman since 2021. Prior to this, he worked as CEO of Merck Serono.

Read Hide full bio of Young-Joo Kim

Kim Seong-gon

Director Non Executive Board

Lim Jong-Rae

Director Non Executive Board

Kang In-Soo

Director Non Executive Board Since: 2019

Chang Dong-shin

Director Non Executive Board Since: 2022
Gain a 360-degree view of Chong Kun Dang Pharmaceutical Corp. and make more informed decisions for your business Gain a 360-degree view of Chong Kun Dang Pharmaceutical Corp. and make more informed decisions for your business Find out more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Start of HubSpot Embed Code End of HubSpot Embed Code